PMID- 23435305 OWN - NLM STAT- MEDLINE DCOM- 20140110 LR - 20130627 IS - 1473-5571 (Electronic) IS - 0269-9370 (Linking) VI - 27 IP - 11 DP - 2013 Jul 17 TI - Endoplasmic reticulum aminopeptidase 2 haplotypes play a role in modulating susceptibility to HIV infection. PG - 1697-706 LID - 10.1097/QAD.0b013e3283601cee [doi] AB - OBJECTIVE: Haplotype-specific alternative splicing of the endoplasmic reticulum (ER) aminopeptidase type 2 (ERAP2) gene results in either full-length (FL, haplotype A) or alternatively spliced (AS, haplotype B) mRNA. As ERAP2 trims peptides loaded on major histocompatibility complex (MHC) class I and CD8 T lymphocytes protect against viral infections, we analysed its role in resistance to HIV-1 infection. METHODS: ERAP2 polymorphisms were genotyped using a TaqMan probe, and human leukocyte antigen (HLA) typing of class-I HLAB locus was performed by single specific primers-polymerase chain reaction method. To verify whether ERAP2 genotype influences susceptibility to HIV-1 infection in vitro we performed HIV-1 infection assay. We evaluated antigen presentation pathway with PCR array and the viral antigen p24 with ELISA. RESULTS: Genotype analysis in 104 HIV-1-exposed seronegative individuals (HESNs) exposed to HIV through IDU-HESN and 130 controls from Spain indicated that hapA protects from HIV infection. Meta-analysis with an Italian cohort of sexually exposed HESN yielded a P value of 7.6 x 10. HLAB typing indicated that the HLA-B*57 allele is significantly more common than expected among HESN homozygous for haplotype A (homoA). Data obtained in a cohort of 139 healthy Italian controls showed that following in-vitro HIV-1 infection the expression of ERAP2-FL and a number of genes involved in antigen presentation as well as of MHC class I on the surface of CD45 cells was significantly increased in homoA cells; notably, homoA peripheral blood mononuclear cells, but not isolated CD4 cells, were less susceptible to HIV-1 infection. CONCLUSION: ERAP2 hapA is correlated with resistance to HIV-1 infection, possibly secondarily to its effect on antigen processing and presentation. FAU - Biasin, Mara AU - Biasin M AD - Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy. mara.biasin@unimi.it FAU - Sironi, Manuela AU - Sironi M FAU - Saulle, Irma AU - Saulle I FAU - de Luca, Mariacristina AU - de Luca M FAU - la Rosa, Francesca AU - la Rosa F FAU - Cagliani, Rachele AU - Cagliani R FAU - Forni, Diego AU - Forni D FAU - Agliardi, Cristina AU - Agliardi C FAU - lo Caputo, Sergio AU - lo Caputo S FAU - Mazzotta, Francesco AU - Mazzotta F FAU - Trabattoni, Daria AU - Trabattoni D FAU - Macias, Juan AU - Macias J FAU - Pineda, Juan A AU - Pineda JA FAU - Caruz, Antonio AU - Caruz A FAU - Clerici, Mario AU - Clerici M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - AIDS JT - AIDS (London, England) JID - 8710219 RN - 0 (HIV Core Protein p24) RN - 0 (HLA-B Antigens) RN - EC 3.4.11.- (Aminopeptidases) RN - EC 3.4.11.- (ERAP2 protein, human) SB - IM MH - Aminopeptidases/*genetics MH - *Disease Resistance MH - Enzyme-Linked Immunosorbent Assay MH - HIV Core Protein p24/biosynthesis MH - HIV Infections/*genetics MH - HIV-1/genetics/growth & development MH - HLA-B Antigens/genetics MH - Haplotypes MH - Humans MH - Italy MH - Male MH - Polymerase Chain Reaction MH - *Polymorphism, Single Nucleotide MH - Spain EDAT- 2013/02/26 06:00 MHDA- 2014/01/11 06:00 CRDT- 2013/02/26 06:00 PHST- 2013/02/26 06:00 [entrez] PHST- 2013/02/26 06:00 [pubmed] PHST- 2014/01/11 06:00 [medline] AID - 10.1097/QAD.0b013e3283601cee [doi] PST - ppublish SO - AIDS. 2013 Jul 17;27(11):1697-706. doi: 10.1097/QAD.0b013e3283601cee.